309 related articles for article (PubMed ID: 24964695)
21. Thai health technology assessment guideline development.
Teerawattananon Y; Chaikledkaew U
J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S11-5. PubMed ID: 19253483
[TBL] [Abstract][Full Text] [Related]
22. The greatest happiness of the greatest number? Policy actors' perspectives on the limits of economic evaluation as a tool for informing health care coverage decisions in Thailand.
Teerawattananon Y; Russell S
BMC Health Serv Res; 2008 Sep; 8():197. PubMed ID: 18817579
[TBL] [Abstract][Full Text] [Related]
23. Where are the limits of cost-effectiveness analysis and health technology assessment?
Culyer AJ
J Med Assoc Thai; 2014 May; 97 Suppl 5():S1-2. PubMed ID: 24964691
[No Abstract] [Full Text] [Related]
24. [Evaluation of medical methods--can we rely on cost-benefit-analysis?].
Kristiansen IS; Stavem K; Linnestad K; Pedersen KM
Tidsskr Nor Laegeforen; 2003 Mar; 123(5):657-60. PubMed ID: 12683199
[No Abstract] [Full Text] [Related]
25. The need for economic evaluation of telemedicine to evolve: the experience in Alberta, Canada.
Hailey D; Jennett P
Telemed J E Health; 2004; 10(1):71-6. PubMed ID: 15104918
[TBL] [Abstract][Full Text] [Related]
26. Policy making and roles of health technology assessment.
Tantivess S
J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S88-99. PubMed ID: 19253491
[TBL] [Abstract][Full Text] [Related]
27. An economic perspective on childhood obesity: recent findings on cost of illness and cost effectiveness of interventions.
John J; Wolfenstetter SB; Wenig CM
Nutrition; 2012 Sep; 28(9):829-39. PubMed ID: 22452837
[TBL] [Abstract][Full Text] [Related]
28. The challenges of economic evaluations of remote technical health interventions.
Kennedy CA
Clin Invest Med; 2005 Apr; 28(2):71-4. PubMed ID: 15909483
[TBL] [Abstract][Full Text] [Related]
29. Problems of using modelling in the economic evaluation of health care.
Sheldon TA
Health Econ; 1996; 5(1):1-11. PubMed ID: 8653188
[No Abstract] [Full Text] [Related]
30. Values and evidence colliding: health technology assessment in child health.
Ungar WJ; Prosser LA; Burnett HF
Expert Rev Pharmacoecon Outcomes Res; 2013 Aug; 13(4):417-9. PubMed ID: 23977967
[No Abstract] [Full Text] [Related]
31. Making sensible rationing: the use of economic evidence and the need for methodological standards.
Tangcharoensathien V; Kamolratanakul P
J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S4-7. PubMed ID: 19253481
[TBL] [Abstract][Full Text] [Related]
32. Guidelines for health technology assessment in Thailand (second edition)--the development process.
Chaikledkaew U; Kittrongsiri K
J Med Assoc Thai; 2014 May; 97 Suppl 5():S4-9. PubMed ID: 24964693
[TBL] [Abstract][Full Text] [Related]
33. Cost collection and analysis for health economic evaluation.
Smith KA; Rudmik L
Otolaryngol Head Neck Surg; 2013 Aug; 149(2):192-9. PubMed ID: 23641023
[TBL] [Abstract][Full Text] [Related]
34. Historical development of health technology assessment in Thailand.
Teerawattananon Y; Tantivess S; Yothasamut J; Kingkaew P; Chaisiri K
Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():241-52. PubMed ID: 19527543
[TBL] [Abstract][Full Text] [Related]
35. Approaches for economic evaluations of health care technologies.
Tarride JE; Blackhouse G; Bischof M; McCarron EC; Lim M; Ferrusi IL; Xie F; Goeree R
J Am Coll Radiol; 2009 May; 6(5):307-16. PubMed ID: 19394571
[TBL] [Abstract][Full Text] [Related]
36. Mental health economics: insights from Brazil.
Cruz L; Lima AF; Graeff-Martins A; Maia CR; Ziegelmann P; Miguel S; Fleck M; Polanczyk C
J Ment Health; 2013 Apr; 22(2):111-21. PubMed ID: 23574503
[TBL] [Abstract][Full Text] [Related]
37. Sensitivity analysis for handling uncertainty in an economic evaluation.
Limwattananon S
J Med Assoc Thai; 2014 May; 97 Suppl 5():S59-64. PubMed ID: 24964700
[TBL] [Abstract][Full Text] [Related]
38. Economic data transferability for HTA: are we there yet?
Manca A
Value Health; 2009 Jun; 12(4):407. PubMed ID: 19900247
[No Abstract] [Full Text] [Related]
39. How do we evaluate the economics of health care?
Kumar S; Williams AC; Sandy JR
Eur J Orthod; 2006 Dec; 28(6):513-9. PubMed ID: 17035484
[TBL] [Abstract][Full Text] [Related]
40. Why cost-of-illness studies are important and inform policy.
Durand-Zaleski I
Vasc Med; 2008 Aug; 13(3):251-3. PubMed ID: 18687763
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
